Literature DB >> 166826

Relation between thyroid iodine content and the accumulation and oxidation of [35-S] Methimazole in the rat.

B Marchant, P D Papapetrou, W D Alexander.   

Abstract

The thyroid accumulation and oxidation of a single intraperitoneal dose of [35-S] methimazole has been studied in iodine-deficient, normal and iodine-treated rats. A highly significant positive linear correlation was found between the thyroid oxidation of methimazole to sulfate and intrathyroidal iodine content. A single dose of potassium iodide given intraperitoneally (ip) to rats 1 h before administration of [35-S] methimazole (1 mg/kg ip) increased the thyroid accumulation and oxidation of methimazole. Conversely, the thyroids of rats maintained on a low iodine diet for 21 days showed a markedly reduced capacity to accumulate and oxidize methimazole. The level of oxidation found in the iodine-deficient, normal and iodide-treated groups was 0.21, 4.15 and 12.6 nmol sulfate/g thyroid respectively. The animals maintained on the low iodine diet for 21 days showed significant increases in thyroid weight and thus the decrease in methimazole oxidation occurred in spite of increased stimulation by endogenous TSH. These results show that the intrathyroidal iodine content is a critical factor in the metabolism of methimazole in the thyroid.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 166826     DOI: 10.1210/endo-97-1-154

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  3 in total

Review 1.  Pharmacokinetics of antithyroid drugs.

Authors:  G Benker; D Reinwein
Journal:  Klin Wochenschr       Date:  1982-06-01

2.  Pharmacokinetics of methimazole in humans.

Authors:  J H Hengstmann; H Hohn
Journal:  Klin Wochenschr       Date:  1985-12-02

Review 3.  Very rare case of Graves' disease with resistance to methimazole: a case report and literature review.

Authors:  Yusaku Mori; Munenori Hiromura; Michishige Terasaki; Hideki Kushima; Makoto Ohara; Tomoyasu Fukui; Yasuyoshi Takahashi; Sho-Ichi Yamagishi
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.